Drug profile · INN
meningococcal group a, c, w-135 and y conjugate vaccine
MENQUADFI
meningococcal group a, c, w-135 and y conjugate vaccine (MENQUADFI) is a immunostimulant.
EMA: approved Antiinfectives for systemic use (J07) J07AH08
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — meningococcal group a, c, w-135 and y conjugate vaccine
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.83
Quick answer
meningococcal group a, c, w-135 and y conjugate vaccine (MENQUADFI) is a immunostimulant.
Key facts
INN meningococcal group a, c, w-135 and y conjugate vaccine
Brand MENQUADFI
Mechanism Immunostimulant
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07AH08
Mechanism of action
Immunostimulant
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is meningococcal group a, c, w-135 and y conjugate vaccine?
meningococcal group a, c, w-135 and y conjugate vaccine (MENQUADFI) is a immunostimulant.
What is the brand name for meningococcal group a, c, w-135 and y conjugate vaccine?
MENQUADFI is a marketed brand name for meningococcal group a, c, w-135 and y conjugate vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.